COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 2842: Articles 28411-28420  | Next

Studying the pathophysiology of coronavirus disease 2019 - a protocol for the Berlin prospective COVID-19 patient cohort (Pa- COVID-19)
Kurth, F., Roennefarth, M., Thibeault, C., Corman, V. M., Mueller-Redetzky, H., Mittermaier, M., Ruwwe-Gloesenkamp, C., Krannich, A., Schmidt, S., Kretzler, L., Dang-Heine, C., Rose, M., Hummel, M., Hocke, A., Huebner, R. H., Mall, M. A., Roehmel, J., Landmesser, U., Pieske, B., Knauss, S., Endres, M., Spranger, J., Mockenhaupt, F. P., Tacke, F., Treskatsch, S., Angermair, S., Siegmund, B., Spies, C., Weber-Carstens, S., Eckardt, K.-U., Uhrig, A., Zoller, T., Drosten, C., Suttorp, N., Witzenrath, M., Hippenstiel, S., von Kalle, C., Sander, L. E.
10.1101/2020.05.06.20092833 — Posted: 2020-05-11
Multi-omics study revealing tissue-dependent putative mechanisms of SARS-CoV-2 drug targets on viral infections and complex diseases
Zheng, J., Zhang, Y., Liu, Y., Baird, D., Liu, X., Wang, L., Zhang, H., Davey Smith, G., Gaunt, T.
10.1101/2020.05.07.20093286 — Posted: 2020-05-11
Rapid increase of Care Homes reporting outbreaks a sign of eventual substantial disease burden
Hall, I., Pellis, L., House, T., Lewkowicz, H., Sedgwick, J., Gent, N.
10.1101/2020.05.07.20089243 — Posted: 2020-05-11 Discussion: Onsite
Selection of homemade mask materials for preventing transmission of COVID-19: a laboratory study
Wang, D., You, Y., Zhou, X., Zong, Z., Huang, H., Zhang, H., Yong, X., Cheng, Y., Yang, L., Guo, Q., Long, Y., Liu, Y., Huang, J., Du, L.
10.1101/2020.05.06.20093021 — Posted: 2020-05-11
Health and Demographic Impact on COVID-19 Infection and Mortality in US Counties
Xie, Z., Li, D.
10.1101/2020.05.06.20093195 — Posted: 2020-05-11
Spread of Covid-19 in the United States is controlled
Hu, Z., Ge, Q., Li, S., Xu, T., Boerwinkle, E., Jin, L., Xiong, M.
10.1101/2020.05.04.20091272 — Posted: 2020-05-11
Social Distancing is Effective at Mitigating COVID-19 Transmission in the United States
Badr, H., Du, H., Marshall, M., Dong, E., Squire, M., Gardner, L. M.
10.1101/2020.05.07.20092353 — Posted: 2020-05-11 Discussion: Onsite | Offsite
Screening of SARS-CoV-2 among homeless people, asylum seekers and other people living in precarious conditions in Marseille, France, March April 2020.
Ly, T. D. A., Hoang, V. T., Goumballa, N., Louni, M., Canard, N., Dao, T. L., Medkour, H., Borg, A., Bardy, K., Esteves-Vieira, V., Filosa, V., Davoust, B., Mediannikov, O., Fournier, P.-E., Raoult, D., Gautret, P.
10.1101/2020.05.05.20091934 — Posted: 2020-05-11
Monitoring the Covid-19 epidemics in Italy from mortality data
del Re, D., Meridiani, P.
10.1101/2020.05.07.20092775 — Posted: 2020-05-11
How many COVID-19 cases could have been prevented in the US if its interventions were as effective as those in China and South Korea?
Liu, K., Song, Y., Li, M., Shen, Z., Wang, M., Wu, J.
10.1101/2020.05.06.20092981 — Posted: 2020-05-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).